Publications by authors named "David Iser"

Claim this Profile
R
Refractory coeliac disease or something else?
Penelope McKelvie, Mandeep Singh, David M Iser, H Miles Prince, Mohammad Ali Bazargan

Pathology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes of a Decentralized, Nurse-Led, Statewide Model of Care for Hepatitis C Among People in Prison in Victoria, Australia.
Michael B MacIsaac, Timothy Papaluca, Lucy McDonald, Anne Craigie, Amy Edwards, David Iser

Clin Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Connecting patients notified with hepatitis C to treatment (CONNECT Study): A randomized controlled trial of active case management by a health department to support primary care practitioners.
Tafireyi Marukutira, Rachel Barter, Karen P Moore, Margaret E Hellard, Jacqui Richmond, David M Iser

Int J Drug Policy· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study.
Marianne Martinello, Sanjay Bhagani, David Shaw, Chloe Orkin, Graham Cooke, David Iser

JHEP Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection.
Olav Dalgard, Alain H Litwin, Oren Shibolet, Jason Grebely, Ronald Nahass, David Iser

J Addict Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.
Jason Grebely, Gregory J Dore, Frederick L Altice, Brian Conway, Alain H Litwin, David Iser

Ann Intern Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Care Navigation Increases Initiation of Hepatitis C Treatment After Release From Prison in a Prospective Randomized Controlled Trial: The C-LINK Study.
Timothy Papaluca, Anne Craigie, Lucy McDonald, Amy Edwards, Rebecca Winter, David Iser

Open Forum Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Australian consensus recommendations for the management of hepatitis B.
John S Lubel, Simone I Strasser, Alexander J Thompson, Benjamin C Cowie, Jennifer MacLachlan, David Iser

Med J Aust· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retreatment for hepatitis C virus direct acting antiviral therapy virological failure in primary and tertiary settings: the REACH-C cohort.
Joanne M Carson, Behzad Hajarizadeh, Josh Hanson, James O'Beirne, David Iser

J Viral Hepat· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study.
Jasmine Yee, Joanne M Carson, Behzad Hajarizadeh, Joshua Hanson, James O'Beirne, David Iser

Hepatol Commun· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-site, nurse-coordinated hepatitis C model of care in primary care and community services in Melbourne, Australia.
Brendan L Harney, Bradley Whitton, Emma Paige, Rebecca Brereton, Robert Weiss, David Iser

Liver Int· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol.
Tafireyi Marukutira, Karen P Moore, Margaret Hellard, Jacqui Richmond, Kate Turner, David Iser

BMJ Open· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial.
Joseph S Doyle, Daniela K van Santen, David Iser, Joe Sasadeusz, Mark O'Reilly

Clin Infect Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort.
Joanne M Carson, Behzad Hajarizadeh, Josh Hanson, James O'Beirne, David Iser

Int J Drug Policy· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A qualitative exploration of enablers for hepatitis B clinical management among ethnic Chinese in Australia.
Yinzong Xiao, Jack Wallace, Alex Thompson, Margaret Hellard, Caroline van Gemert, David Iser

J Viral Hepat· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In support of community-based hepatitis C treatment with triage of people at risk of cirrhosis to specialist care.
Amanda J Wade, Joseph S Doyle, Bridget Draper, Jessica Howell, David Iser

J Viral Hepat· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Markers of HIV Infection on Change in Liver Stiffness in People With HIV and Hepatitis C Virus Co-infection After Treatment and Cure of Hepatitis C.
Daniela K van Santen, Paul A Agius, Joseph Sasadeusz, Christopher K Fairley, William Sievert, David Iser

J Acquir Immune Defic Syndr· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C.
Timothy Papaluca, Anne Craigie, Lucy McDonald, Amy Edwards, Michael MacIsaac, David Iser

PLoS One· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with age.
Jessica Howell, David Anderson, Stephen Bloom, John Lubel, William Kemp, David Iser

J Hepatol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject Drugs.
Amanda J Wade, Joseph S Doyle, Edward Gane, Catherine Stedman, Bridget Draper, David Iser

Clin Infect Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retreatment with elbasvir, grazoprevir, sofosbuvir ± ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapse.
Timothy Papaluca, Marie Sinclair, Paul Gow, Stephen Pianko, William Sievert, David Iser

Liver Int· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective prison-based treatment and linkage to care after release.
Timothy J Papaluca, George Tambakis, David Iser, Alexander J Thompson

Lancet Infect Dis· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care.
Timothy Papaluca, Lucy McDonald, Anne Craigie, Annabelle Gibson, Paul Desmond, David Iser

J Hepatol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection.
Swee Lin G Chen Yi Mei, Alexander J Thompson, Britt Christensen, Georgina Cunningham, Lucy McDonald, David Iser

PLoS One· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.
Daniel F Wallace, Cameron J McDonald, Lesa Ostini, David Iser, Annabel Tuckfield

Am J Hematol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis